Update of a prognostic survival model in head and neck squamous cell carcinoma patients treated with immune checkpoint inhibitors using an expansion cohort.
Issa M, Klamer BG, Mladkova N, Laliotis GI, Karivedu V, Bhateja P, Byington C, Dibs K, Pan X, Chakravarti A, Grecula J, Jhawar SR, Mitchell D, Baliga S, Old M, Carrau RL, Rocco JW, Blakaj DM, Bonomi M.
Issa M, et al. Among authors: mladkova n.
BMC Cancer. 2022 Jul 14;22(1):767. doi: 10.1186/s12885-022-09809-5.
BMC Cancer. 2022.
PMID: 35836204
Free PMC article.